NRT Smoking Cessation Aids in the USA
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
Table 1 Retail Sales of Homoeopathy 2000-2005
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.5 Leading Company Profile: Bayer Corporation
Summary 2 Bayer Corp: Operational Indicators 2004
Summary 3 Bayer AG: Production Statistics 2005
Table 8 Bayer Corp: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.6 Leading Company Profile: GlaxoSmithKline Plc
Summary 4 GlaxoSmithKline Plc Operational Indicators 2005
Table 9 GlaxoSmithKline Consumer Health: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.7 Leading Company Profile: Johnson & Johnson Inc
Summary 5 Johnson & Johnson Inc Operational Indicators 2005
Table 10 McNeil Consumer & Specialty Pharmaceuticals: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 11 Neutrogena Corp: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 12 Johnson & Johnson Consumer Products Inc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 13 Advanced Care Products: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.8 Leading Company Profile: NBTY Inc
Summary 6 NBTY Inc Operational Indicators 2005
Summary 7 NBTY Inc Production Statistics 2005
Table 14 NBTY Inc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 15 Rexall Sundown Inc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.9 Leading Company Profile: Novartis AG
Summary 8 Novartis AG Operational Indicators 2005
Summary 9 Novartis AG Production Statistics 2005
Table 16 Novartis Corp: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 17 Ciba Vision Corp: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 18 The Gerber Products Co: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
Table 19 Bristol-Myers Squibb Co: Shares of OTC Healthcare by Subsector by Retail Value 2001-2004
3.10 Leading Company Profile: Pfizer Inc
Summary 10 Pfizer Inc Operational Indicators 2005
Summary 11 Pfizer Inc Production Statistics 2005
Table 20 Pfizer Consumer Healthcare Inc: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.11 Leading Companies: The Procter & Gamble Company
Summary 12 The Procter & Gamble Company Operational Indicators 2005
Table 21 The Procter & Gamble Co Shares of OTC Healthcare by Subsector 2001-2005
3.12 Leading Companies: Schering-Plough Corp
Summary 13 Schering-Plough Corp Operational Indicators 2005
Summary 14 Schering-Plough Corp Production Statistics 2005
Table 22 Schering-Plough Healthcare Products Inc Shares of OTC Healthcare by Subsector 2001-2005
3.13 Leading Companies: Wyeth
Summary 15 Wyeth Operational Indicators 2005
Summary 16 Wyeth Production Statistics 2005
Table 23 Wyeth Consumer Healthcare Shares of OTC Healthcare by Subsector 2001-2005
3.14 Emerging and Niche Companies
Summary 17 Chattem Inc Operational Indicators 2005
Summary 18 Perrigo Co Operational Indicators 2005
3.15 Retail Distribution
Table 24 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 25 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.16 Retailer Activity and Private Label Trends
Table 26 Penetration of Private Label by Sector 2001-2005
3.17 Forecast Market Performance
Table 27 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 28 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. NRT SMOKING CESSATION AIDS SALES
4.1 Number of Smokers
Table 29 Number of Smokers by Gender 2000-2005
4.2 Sector Performance
Table 30 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 31 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 32 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 33 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 34 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 35 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
4.3 New Product Developments
Summary 19 NRT Smoking Cessation Aids: New Product Launches 2004-2005
5. DEFINITIONS
